Literature DB >> 24412293

Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke.

Ximing Mo1, Langan Pi2, Jingjing Yang1, Zhongyuan Xiang1, Aiguo Tang3.   

Abstract

We investigated the activation and pathophysiological roles of indoleamine 2,3-dioxygenase (IDO) and kynurenine aminotransferase (KAT) in patients with ischemic stroke. Patients were recruited from the acute stroke unit of a general hospital within 24 hours post-stroke. The immune transmission turbidity method was used to determine the concentration of serum high-sensitivity C-reactive protein (hsCRP), apolipoprotein A-1 and apolipoprotein B. The concentrations of triglyceride, cholesterol, high density lipoprotein (HDL), low density lipoprotein and non-esterified fatty acids were determined using an enzymatic method. Tryptophan (TRP), kynurenine (KYN) and kynurenine acid (KYNA) concentrations were determined by high performance liquid chromatography. The National Institutes of Health Stroke Scale (NIHSS) was used to assess the neurological deficits at admission and 3 weeks post-stroke. The IDO and KAT activity ratio were calculated by KYN/TRP and KYNA/KYN, respectively. The correlation between hsCRP and IDO, KAT and NIHSS score was also analyzed. A total of 81 patients with ischemic stroke and 35 normal controls were recruited. Lower TRP, KYNA, HDL and KAT activity ratio were found in the stroke group compared to the control group (p<0.05). The levels of hsCRP and IDO activity ratio were much higher in the stroke group than the control group (p<0.01). The IDO activity in patients with ischemic stroke showed a positive correlation with hsCRP (r=0.425, p=0.027). In addition, hsCRP and IDO levels were positively associated with the NIHSS score both at admission and 3 weeks post-stroke. These data suggest an inflammatory response characterized by up-regulated IDO activation in ischemic stroke, which might be closely relevant to its pathophysiology.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  High-sensitivity C-reactive protein; Indoleamine 2,3-dioxygenase; Ischemic stroke; Kynurenine acid; Kynurenine aminotransferase

Mesh:

Substances:

Year:  2013        PMID: 24412293     DOI: 10.1016/j.jocn.2013.08.020

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  14 in total

Review 1.  The role of tryptophan metabolism in postpartum depression.

Authors:  Kai-Ming Duan; Jia-Hui Ma; Sai-Ying Wang; ZhengDong Huang; YingYong Zhou; HeYa Yu
Journal:  Metab Brain Dis       Date:  2018-01-06       Impact factor: 3.584

2.  IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; George Anderson; André F Carvalho; Sebastien Duleu; Michel Geffard; Michael Maes
Journal:  Metab Brain Dis       Date:  2017-06-09       Impact factor: 3.584

Review 3.  The Footprint of Kynurenine Pathway in Cardiovascular Diseases.

Authors:  Moein Ala; Seyed Parsa Eftekhar
Journal:  Int J Tryptophan Res       Date:  2022-06-28

Review 4.  The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.

Authors:  María Isabel Cuartero; Juan de la Parra; Alicia García-Culebras; Iván Ballesteros; Ignacio Lizasoain; María Ángeles Moro
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

5.  Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.

Authors:  Esther Jortzik; Kathleen Zocher; Antje Isernhagen; Boniface M Mailu; Stefan Rahlfs; Giampietro Viola; Sergio Wittlin; Nicholas H Hunt; Heiko Ihmels; Katja Becker
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

6.  The novel targets of DL-3-n-butylphthalide predicted by similarity ensemble approach in combination with molecular docking study.

Authors:  Yan Wang; Wei Qi; Li Zhang; Zhenguang Ying; Ou Sha; Chunman Li; Lanhai Lü; Xiangyan Chen; Zhenzhong Li; Feng Niu; Fang Xue; Dong Wang; Tzi-Bun Ng; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2017-10

Review 7.  Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system.

Authors:  Hae Ung Lee; Zachary E McPherson; Bryan Tan; Agata Korecka; Sven Pettersson
Journal:  J Mol Med (Berl)       Date:  2016-11-17       Impact factor: 4.599

Review 8.  Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.

Authors:  Zsófia Majláth; Nóra Török; József Toldi; László Vécsei
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  Increased urinary excretion of kynurenic acid is associated with non-recovery from acute kidney injury in critically ill patients.

Authors:  Fabienne Aregger; Dominik E Uehlinger; Gerhard Fusch; Aldin Bahonjic; Rene Pschowski; Michael Walter; Joerg C Schefold
Journal:  BMC Nephrol       Date:  2018-02-26       Impact factor: 2.388

10.  Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation.

Authors:  Tomasz Zapolski; Anna Kamińska; Tomasz Kocki; Andrzej Wysokiński; Ewa M Urbanska
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.